Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      WuXi XDC Announces the Mechanical Completion of its Singapore Site, Accelerating the Global Expansion of Bioconjugates Manufacturing
      Biotech

      WuXi XDC Announces the Mechanical Completion of its Singapore Site, Accelerating the Global Expansion of Bioconjugates Manufacturing

      July 1, 2025
      Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan
      Biotech

      Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

      June 30, 2025
      ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment
      Biotech

      ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment

      June 29, 2025
      Debut Named to TIME’s List of the TIME100 Most Influential Companies 2025
      Biotech

      Debut Named to TIME’s List of the TIME100 Most Influential Companies 2025

      June 28, 2025
      FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still’s disease
      Biotech

      FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still’s disease

      June 28, 2025
      Challenge accepted: New funding for ambitious projects within biomanufacturing, cardiometabolic diseases, and artificial intelligence
      Biotech

      Challenge accepted: New funding for ambitious projects within biomanufacturing, cardiometabolic diseases, and artificial intelligence

      June 27, 2025
      NORTHEAST GEORGIA MEDICAL’S LEVEL I TRAUMA CENTER ENROLLS 170TH PATIENT FOR PRYTIME MEDICAL’S INTERNATIONAL STUDY
      Biotech

      NORTHEAST GEORGIA MEDICAL’S LEVEL I TRAUMA CENTER ENROLLS 170TH PATIENT FOR PRYTIME MEDICAL’S INTERNATIONAL STUDY

      June 27, 2025
      Zentiva calls for Pause – Repair – Relaunch of the Urban Wastewater Treatment Directive (UWWTD)
      Biotech

      Zentiva calls for Pause – Repair – Relaunch of the Urban Wastewater Treatment Directive (UWWTD)

      June 27, 2025
      Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies
      Biotech

      Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies

      June 26, 2025
      Theravance Biopharma Announces Approval of YUPELRI® (revefenacin) by China’s NMPA
      Biotech

      Theravance Biopharma Announces Approval of YUPELRI® (revefenacin) by China’s NMPA

      June 26, 2025
      « 1 … 23 24 25 26 27 … 142 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026